Presentations include initial results from preclinical studies of expanded pipeline programs in immune-mediated and metabolic diseases Presentations include initial results from preclinical studies of expanded pipeline programs in immune-mediated and metabolic diseases

Original post:
Sigilon Therapeutics Announces Presentations at the American Society of Gene and Cell Therapy 24th Annual Meeting

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh